$185.48
1.26[0.68%]
At close: Apr 24
$185.48
0[0.00%]
PreMarket: 4:52AM EDT
Latest News for ResMed Stock (NYSE:RMD)
ResMed Stock (NYSE: RMD)
Categories: All
Tuesday, April 23, 2024
Monday, April 22, 2024
Wednesday, April 17, 2024
Monday, April 15, 2024
Monday, April 08, 2024
Monday, April 01, 2024
Thursday, March 28, 2024
Wednesday, March 27, 2024
Tuesday, March 26, 2024
Thursday, March 07, 2024
Tuesday, February 06, 2024
Thursday, February 01, 2024
Tuesday, January 30, 2024
Friday, January 26, 2024
Thursday, January 25, 2024
- UBS Maintains Neutral on ResMed, Raises Price Target to $180Benzinga Newsdesk - Jan 25, 2024, 3:01PM
- Cracking The Code: Understanding Analyst Reviews For ResMedBenzinga Insights - Jan 25, 2024, 1:00PM
- RBC Capital Maintains Sector Perform on ResMed, Raises Price Target to $182Benzinga Newsdesk - Jan 25, 2024, 11:49AM
- ResMed shares are trading higher after the company reported better-than-expected Q2 financial results.Benzinga Newsdesk - Jan 25, 2024, 9:27AM
- AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For ThursdayAvi Kapoor - Jan 25, 2024, 7:42AM
- Needham Maintains Buy on ResMed, Raises Price Target to $215Benzinga Newsdesk - Jan 25, 2024, 6:12AM
Wednesday, January 24, 2024
Tuesday, January 23, 2024
Friday, January 12, 2024
Wednesday, January 10, 2024
Tuesday, January 09, 2024
- Demystifying ResMed: Insights From 5 Analyst ReviewsBenzinga Insights - Jan 9, 2024, 4:01PM
- ResMed shares are trading higher after JP Morgan maintained an Overweight rating on the stock and raised its price target from $160 to $195.Benzinga Newsdesk - Jan 9, 2024, 10:16AM
- JP Morgan Maintains Overweight on ResMed, Raises Price Target to $195Benzinga Newsdesk - Jan 9, 2024, 9:33AM
Monday, December 25, 2023
Friday, December 22, 2023
Wednesday, December 20, 2023
Thursday, December 14, 2023
Monday, December 11, 2023
Thursday, December 07, 2023
Thursday, November 30, 2023
Friday, November 17, 2023
Friday, November 10, 2023
Thursday, November 09, 2023
- ResMed Adopts New Operating Model To Accelerate Long-Term Growth; Rob Douglas, President And Chief Operating Officer, To Retire January 1, 2024.Benzinga Newsdesk - Nov 9, 2023, 5:25PM
- ResMed shares are trading lower amid weakness in healthcare equipment stocks after Becton, Dickinson And Company reported mixed Q4 financial results and issued FY24 adjusted EPS and revenue guidance below estimates.Benzinga Newsdesk - Nov 9, 2023, 12:18PM